ClinicalTrials.gg
CompletedNCT02092311CMMVUpdated Jul 3, 2015Results posted

Assessing the Rates of Major Complications in Combined Mini-incision Microscopic Varicocelectomy

An interventional study of Combined Microscopic Varicocelectomy and Inguinal and Subinguinal varicocelectomy in Varicocele, sponsored by Omid Fertility Center. Completed at 1 site in Iran, Islamic Republic of. Open to male participants. Per ClinicalTrials.gov, last updated 2015-07-03.

Sponsored by Omid Fertility Center · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
570
Allocation
Randomized
Sex
Male
01

Study summary

The purpose of this study is to determine the rates of major post-varicocelectomy complications (Recurrence, Hydrocele and Testicular Atrophy) in patients operated with a new method named Combined Mini-incision Microscopic Varicocelectomy. The study hypothesis is that using this method will lead to less major complications of recurrence, hydrocele, and also less incidental injuries to the arteries that will result less testicular atrophy

Read the detailed description

The sample is selected from the patients who were referred to our center for surgical treatment of varicocele. Most of them were diagnosed after being evaluated for infertility.

All of them were operated by a single experienced and expert microscopic surgeon.

Informed consent is received from all of the possible candidates in accordance to national and Declaration of Helsinki guidelines.

Selection of patients for undergoing Combined varicocelectomy was done during the operation due to the nature of including criteria.

In this method after making an incision at inguinal level, veins are evaluated and if the including criteria is existed, only external spermatic vein is ligated at the depth of the inguinal canal and other veins are left alone for prevention of damage to the artery. Then another mini incision is made at high inguinal level and the rest of surgery is conducted by retroperitoneal approach.

The incidence rate of major complications (recurrence, testicular atrophy, hydrocele) of experimental group is compared to the incidence rate of the same complications of the patients in control group that were operated with currently common inguinal and subinguinal microscopic varicocelectomy accompanied by testicular delivery, an approach that is suggested by Goldstein and associates.

The study hypothesis is that using this method will lead to less major complications including recurrence, hydrocele and also less incidental injuries to the arteries that will result to less testicular atrophy.

02

Conditions studied

  • Varicocele

Browse trials for

Keywords

  • varicocele
  • varicocelectomy
  • complications of varicocelectomy
  • Recurrence of varicocele
  • Post-varicocelectomy testicular atrophy
  • Post-varicocelectomy hydrocele
03

In context

Varicocele

53 studies on the registry are indexed under Varicocele; 15 are open to participants now.

This study's enrollment of 570 is above the median of 72 across 36 interventional studies indexed under Varicocele.

Browse Varicocele studies →

Lead sponsor

This is the only study on the registry with Omid Fertility Center as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Complexity and tortuosity of the veins at inguinal level so that separating and ligation of the vein could lead to artery injury
  • Veins which are contiguous with arteries so that separating and ligation of the vein could lead to artery injury

Exclusion criteria

Exclusion Criteria:

  • Prior surgery at inguinal level such as Herniorrhaphy, Orchiopexy,etc.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
570 participants (actual)

Study arms

  • Experimental
    Combined Microscopic Varicocelectomy

    Patients in this arm were operated with Combined Mini-incision Microscopic approach

    Procedure: Combined Microscopic Varicocelectomy

  • Active comparator
    Inguinal and Subinguinal Varicocelectomy

    Patients in this arm have the same including criteria as Experimental arm but they were operated with conventional and currently popular approach of Microscopic Inguinal and Sub inguinal varicocelectomy suggested by Goldstien and associates

    Procedure: Inguinal and Subinguinal varicocelectomy

Interventions

  • ProcedureCombined Microscopic Varicocelectomy

    After making a mini-incision at inguinal level, veins are evaluated, and if the including criteria (Complexity and tortuosity of the veins and/or existence of veins that are contiguous with arteries so that separating and ligation of the veins could jeopardize the artery) are existed, only external spermatic vein, if dilated, is ligated at the depth of the inguinal canal, and other veins are left alone for prevention of damage to the artery. Subsequently, another mini-incision is made at high inguinal level and the rest of surgery is conducted by retroperitoneal approach, which is also done microscopically

  • ProcedureInguinal and Subinguinal varicocelectomy

    Microscopic Inguinal and Sub inguinal varicocelectomy, recommended by Goldstein and associates, are currently popular approaches. In this approach the spermatic cord structures are pulled up and out of the wound so that the testicular artery, lymphatics, and small periarterial veins may be more easily identified. In addition, an inguinal or subinguinal approach allows access to external spermatic and even gubernacular veins.

06

What researchers measure

Primary outcomes

  1. Recurrent Varicocele

    post-varicocelectomy recurrence is measured by physical exam at intervals of 10 days,3months and 6months after surgery

    Time frame: 6 months

Secondary outcomes

  1. Post-varicocelectomy Hydrocele

    Development of hydrocele is assessed by physical exam at intervals of 10 days,3months and 6months after surgery

    Time frame: 6months

Other outcomes

  1. Post-varicocelectomy Testicular Atrophy

    development of testicular atrophy is assessed by physical exam at intervals of 3 and 6 months after surgery

    Time frame: 6months

07

Results

Posted Jun 30, 2014

Participant flow

Participant flow — Overall Study
MilestoneCombined Microscopic VaricocelectomyInguinal and Subinguinal Varicocelectomy
Started285285
Completed285285
Not completed00

Outcome measures

PrimaryRecurrent Varicocele

post-varicocelectomy recurrence is measured by physical exam at intervals of 10 days,3months and 6months after surgery

Time frame:
6 months
Reported as:
Number · participants
Recurrent Varicocele
participantsCombined Microscopic VaricocelectomyInguinal and Subinguinal Varicocelectomy
Recurrent Varicocele216
SecondaryPost-varicocelectomy Hydrocele

Development of hydrocele is assessed by physical exam at intervals of 10 days,3months and 6months after surgery

Time frame:
6months
Reported as:
Number · Participants
Post-varicocelectomy Hydrocele
ParticipantsCombined Microscopic VaricocelectomyInguinal and Subinguinal Varicocelectomy
Post-varicocelectomy Hydrocele00
Other pre-specifiedPost-varicocelectomy Testicular Atrophy

development of testicular atrophy is assessed by physical exam at intervals of 3 and 6 months after surgery

Time frame:
6months
Reported as:
Number · Participants
Post-varicocelectomy Testicular Atrophy
ParticipantsCombined Microscopic VaricocelectomyInguinal and Subinguinal Varicocelectomy
Post-varicocelectomy Testicular Atrophy00

Adverse events

Collected over 6 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Combined Microscopic Varicocelectomy—0/285 (0%)2/285 (0.7%)
Inguinal and Subinguinal Varicocelectomy—0/285 (0%)16/285 (5.6%)
Most frequent serious events
Most frequent serious events
EventCombined Microscopic VaricocelectomyInguinal and Subinguinal Varicocelectomy
Testicular AtrophyReproductive system and breast disorders0/2850/285
Most frequent other events
Most frequent other events
EventCombined Microscopic VaricocelectomyInguinal and Subinguinal Varicocelectomy
Recurrent VaricoceleReproductive system and breast disorders2/28516/285
HydroceleReproductive system and breast disorders0/2850/285

Baseline characteristics

Age, Continuous
Age, Continuous(years)Combined Microscopic VaricocelectomyInguinal and Subinguinal VaricocelectomyTotal
Mean31.2 (16 to 40)31.8 (22 to 39)31.5 (16 to 40)
Sex: Female, Male
Sex: Female, Male(Participants)Combined Microscopic VaricocelectomyInguinal and Subinguinal VaricocelectomyTotal
Female000
Male285285570
Region of Enrollment
Region of Enrollment(participants)Combined Microscopic VaricocelectomyInguinal and Subinguinal VaricocelectomyTotal
Iran, Islamic Republic of285285570
08

Study locations

1 site
  • Omid fertility center
    Tehran, Iran, Islamic Republic of
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2006, a primary completion of Sep 2013 and a completion of Jun 2015. It does not say whether these dates are actual or estimated.

Results were first posted in Jun 2014, 9 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 18, 2014
First posted
Mar 20, 2014
Start
Jan 2006
Primary completionActual
Sep 2013
CompletionActual
Jun 2015
Results first posted
Jun 30, 2014
Last update
Jul 3, 2015
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 3, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02092311
Lead sponsor
Omid Fertility Center
Responsible party
Sponsor
First posted
Mar 20, 2014
Start date
Jan 2006
Primary completion
Sep 2013
Completion
Jun 2015
Results posted
Jun 30, 2014
Last update
Jul 3, 2015

Study contacts

Omid Pouyan, MD
study director · Omid Fertility Center
Navid Pooyan, MD
principal investigator · Omid Fertility Center
Robabeh Taheri Panah, MD
study chair · Infertility and Reproductive Health research center of Shahid Beheshti university of medical sciences
Ashraf Ale Yasin, MD
study chair · Omid Fertility Center
Marzieh Agha Hosseini, MD
study chair · Omid Fertility Center
Hojatollah Saeidi Saeid Abadi, P.H.D
study chair · Omid FC

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion